Ribon Therapeutics picks up $65m

Ribon Therapeutics, a clinical stage biotechnology company, has secured $65 million in financing.

Ribon Therapeutics, a clinical stage biotechnology company, has secured $65 million in financing. Deerfield Management and U.S. Venture Partners led the round.

Source: Press Release